- Home
- NAOV vs TCRT Comparison
NAOV vs TCRT Comparison
Compare NAOV & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAOV
- TCRT
- Stock Information
- Founded
- NAOV 2003
- TCRT 1998
- Country
- NAOV United States
- TCRT United States
- Employees
- NAOV N/A
- TCRT N/A
- Industry
- NAOV Industrial Specialties
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- NAOV Health Care
- TCRT Health Care
- Exchange
- NAOV Nasdaq
- TCRT Nasdaq
- Market Cap
- NAOV 2.4M
- TCRT 2.6M
- IPO Year
- NAOV N/A
- TCRT N/A
- Fundamental
- Price
- NAOV $0.38
- TCRT $1.68
- Analyst Decision
- NAOV
- TCRT
- Analyst Count
- NAOV 0
- TCRT 0
- Target Price
- NAOV N/A
- TCRT N/A
- AVG Volume (30 Days)
- NAOV 6.7M
- TCRT 12.3K
- Earning Date
- NAOV 04-07-2025
- TCRT 03-31-2025
- Dividend Yield
- NAOV N/A
- TCRT N/A
- EPS Growth
- NAOV N/A
- TCRT N/A
- EPS
- NAOV N/A
- TCRT N/A
- Revenue
- NAOV $3,291,000.00
- TCRT $7,000.00
- Revenue This Year
- NAOV N/A
- TCRT N/A
- Revenue Next Year
- NAOV N/A
- TCRT N/A
- P/E Ratio
- NAOV N/A
- TCRT N/A
- Revenue Growth
- NAOV 227.79
- TCRT N/A
- 52 Week Low
- NAOV $0.36
- TCRT $1.50
- 52 Week High
- NAOV $1.27
- TCRT $26.00
- Technical
- Relative Strength Index (RSI)
- NAOV 39.60
- TCRT 48.71
- Support Level
- NAOV $0.36
- TCRT $1.59
- Resistance Level
- NAOV $0.71
- TCRT $1.70
- Average True Range (ATR)
- NAOV 0.06
- TCRT 0.09
- MACD
- NAOV -0.00
- TCRT 0.01
- Stochastic Oscillator
- NAOV 6.19
- TCRT 69.23
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.